BioCentury
ARTICLE | Clinical News

Topiglan: MCHM began a trial in 30 healthy volunteers to assess the tolerability of a reformulated version of Topiglan. The company said the first reformulation

July 1, 2002 7:00 AM UTC

MacroChem Corp. (MCHM), Lexington, Mass. Product: Topiglan Business: Urological Therapeutic category: Vasodilation Target: Vascular smooth muscle cells Description: Topical alprostadil prostaglandin E...